{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T05:36:33Z","timestamp":1737783393313,"version":"3.33.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,24]]},"abstract":"<jats:p>Prostate cancer is epithelial malignant prostate hyperplasia caused by a tumor. We found prostate cancer GSE141551 and GSE200879 profiles from gene expression omnibus database, followed by differentially expressed genes (DEGs) analysis, weighted gene co-expression network analysis, protein\u2013protein interaction analysis, gene function enrichment analysis, and comparative toxicology database analysis. Finally, the gene expression heat map was drawn, and miRNA information regulating core DEGs was retrieved. A total of 1151 DEGs were found, most of them focusing on systematic development, cell development, cell differentiation, regulation of multicellular biological processes, anatomical morphogenesis, MAPK signaling pathway, proteoglycans in cancer, fluid shear stress, and atherosclerosis. The core genes (MYL9, TAGLN, SMTN, CNN1, MYH11, MYLK, MYOCD, ACTC1, LMOD1, and TPM2) obtained in end are all lowly expressed in prostate cancer samples and are associated with hypertension, tumor metastasis, prostate tumors, and tumor aggressiveness. LMOD1 and SMTN are lowly expressed in prostate cancer and may be used as markers in prostate cancer nursing.<\/jats:p>","DOI":"10.1097\/md.0000000000041357","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T23:00:12Z","timestamp":1737759612000},"page":"e41357","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Exploring markers in nursing care of prostate cancer"],"prefix":"10.1097","volume":"104","author":[{"given":"Yanting","family":"Zhang","sequence":"first","affiliation":[{"name":"Urology and Metabolic Rehabilitation Center, Beijing Rehabilitation Hospital, Capital Medical University, Xixia Zhuang, Badachu, Shijingshan District, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1782-8218","authenticated-orcid":false,"given":"Fei","family":"Cheng","sequence":"additional","affiliation":[{"name":"Urology and Metabolic Rehabilitation Center, Beijing Rehabilitation Hospital, Capital Medical University, Xixia Zhuang, Badachu, Shijingshan District, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6284-5934","authenticated-orcid":false,"given":"Lixia","family":"Li","sequence":"additional","affiliation":[{"name":"Urology and Metabolic Rehabilitation Center, Beijing Rehabilitation Hospital, Capital Medical University, Xixia Zhuang, Badachu, Shijingshan District, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250124","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1177\/1557988318798279","article-title":"Global trends and prostate cancer: a review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location.","volume":"12","author":"Taitt","year":"2018","journal-title":"Am J Mens Health"},{"key":"R2-20250124","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R3-20250124","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1245\/s10434-022-12151-6","article-title":"GLOBOCAN 2020 report on global cancer burden: challenges and opportunities for surgical oncologists.","volume":"29","author":"Deo","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"R4-20250124","doi-asserted-by":"crossref","first-page":"811044","DOI":"10.3389\/fpubh.2022.811044","article-title":"Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019.","volume":"10","author":"Wang","year":"2022","journal-title":"Front Public Health"},{"key":"R5-20250124","first-page":"228","article-title":"The risk factors of prostate cancer and its prevention: a literature review.","volume":"48","author":"Perdana","year":"2016","journal-title":"Acta Med Indones"},{"issue":"Suppl 1","key":"R6-20250124","first-page":"S3","article-title":"Germline genetics of prostate cancer.","volume":"82 Suppl 1","author":"Khan","year":"2022","journal-title":"Prostate"},{"key":"R7-20250124","doi-asserted-by":"crossref","first-page":"a030361","DOI":"10.1101\/cshperspect.a030361","article-title":"The epidemiology of prostate cancer.","volume":"8","author":"Pernar","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R8-20250124","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3390\/biom12030375","article-title":"Alcohol and prostate cancer: time to draw conclusions.","volume":"12","author":"Macke","year":"2022","journal-title":"Biomolecules"},{"key":"R9-20250124","doi-asserted-by":"crossref","first-page":"20902","DOI":"10.1038\/s41598-022-24511-z","article-title":"Transcriptomics indicate nuclear division and cell adhesion not recapitulated in MCF7 and MCF10A compared to luminal A breast tumours.","volume":"12","author":"Goh","year":"2022","journal-title":"Sci Rep"},{"key":"R10-20250124","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41419-019-1515-3","article-title":"CADM1 is a TWIST1-regulated suppressor of invasion and survival.","volume":"10","author":"Hartsough","year":"2019","journal-title":"Cell Death Dis"},{"key":"R11-20250124","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study.","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol"},{"key":"R12-20250124","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/CCO.0000000000000519","article-title":"The evolving role of diet in prostate cancer risk and progression.","volume":"31","author":"Kaiser","year":"2019","journal-title":"Curr Opin Oncol"},{"key":"R13-20250124","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.mcna.2017.03.009","article-title":"Prevention of prostate cancer morbidity and mortality: primary prevention and early detection.","volume":"101","author":"Barry","year":"2017","journal-title":"Med Clin North Am"},{"key":"R14-20250124","first-page":"e22194","article-title":"Loss-of-function variants within LMOD1 actin-binding site 2 cause pediatric intestinal pseudo-obstruction by impairing protein stability and actin nucleation.","volume":"36","author":"Liu","year":"2022","journal-title":"FASEB J"},{"key":"R15-20250124","doi-asserted-by":"crossref","first-page":"e1007755","DOI":"10.1371\/journal.pgen.1007755","article-title":"Functional regulatory mechanism of smooth muscle cell-restricted LMOD1 coronary artery disease locus.","volume":"14","author":"Nanda","year":"2018","journal-title":"PLoS Genet"},{"key":"R16-20250124","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1074\/jbc.M111.302224","article-title":"Leiomodin 1, a new serum response factor-dependent target gene expressed preferentially in differentiated smooth muscle cells.","volume":"287","author":"Nanda","year":"2012","journal-title":"J Biol Chem"},{"key":"R17-20250124","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12885-022-09541-0","article-title":"LMOD1, an oncogene associated with Lauren classification, regulates the metastasis of gastric cancer cells through the FAK-AKT\/mTOR pathway.","volume":"22","author":"Tan","year":"2022","journal-title":"BMC Cancer"},{"key":"R18-20250124","doi-asserted-by":"crossref","first-page":"879751","DOI":"10.3389\/fphar.2022.879751","article-title":"Transcriptomics and metabolomics identify drug resistance of dormant cell in colorectal cancer.","volume":"13","author":"Xie","year":"2022","journal-title":"Front Pharmacol"},{"key":"R19-20250124","doi-asserted-by":"crossref","first-page":"1073274819831260","DOI":"10.1177\/1073274819831260","article-title":"Identification of potential key genes and pathways in early-onset colorectal cancer through bioinformatics analysis.","volume":"26","author":"Zhao","year":"2019","journal-title":"Cancer Control"},{"key":"R20-20250124","doi-asserted-by":"crossref","first-page":"e1900174","DOI":"10.1002\/pmic.201900174","article-title":"Tissue proteome signatures associated with five grades of prostate cancer and benign prostatic hyperplasia.","volume":"19","author":"Kawahara","year":"2019","journal-title":"Proteomics"},{"key":"R21-20250124","doi-asserted-by":"crossref","first-page":"e0260983","DOI":"10.1371\/journal.pone.0260983","article-title":"Prediction of potential prognostic biomarkers in metastatic prostate cancer based on a circular RNA-mediated competing endogenous RNA regulatory network.","volume":"16","author":"Luo","year":"2021","journal-title":"PLoS One"},{"key":"R22-20250124","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/bs.apha.2017.10.001","article-title":"Smoothelins and the control of muscle contractility.","volume":"81","author":"Murali","year":"2018","journal-title":"Adv Pharmacol"},{"key":"R23-20250124","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1247\/csf.22.65","article-title":"Smoothelin expression characteristics: development of a smooth muscle cell in vitro system and identification of a vascular variant.","volume":"22","author":"van Eys","year":"1997","journal-title":"Cell Struct Funct"},{"key":"R24-20250124","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1083\/jcb.134.2.401","article-title":"Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells.","volume":"134","author":"van der Loop","year":"1996","journal-title":"J Cell Biol"},{"key":"R25-20250124","doi-asserted-by":"crossref","first-page":"9343","DOI":"10.3748\/wjg.v19.i48.9343","article-title":"Smoothelin, a new marker to determine the origin of liver fibrogenic cells.","volume":"19","author":"Lepreux","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R26-20250124","first-page":"792","article-title":"Smoothelin and caldesmon are reliable markers for distinguishing muscularis propria from desmoplasia: a critical distinction for accurate staging colorectal adenocarcinoma.","volume":"7","author":"Roberts","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"R27-20250124","first-page":"153","article-title":"Smoothelin and WT-1 expression in glomus tumors and glomuvenous malformations.","volume":"32","author":"Aneiros-Fernandez","year":"2017","journal-title":"Histol Histopathol"},{"key":"R28-20250124","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/modpathol.2009.9","article-title":"Differential expression of immunohistochemical markers in bladder smooth muscle and myofibroblasts, and the potential utility of desmin, smoothelin, and vimentin in staging of bladder carcinoma.","volume":"22","author":"Council","year":"2009","journal-title":"Mod Pathol"},{"key":"R29-20250124","doi-asserted-by":"crossref","first-page":"104539","DOI":"10.1016\/j.compbiomed.2021.104539","article-title":"Machine learning and network-based models to identify genetic risk factors to the progression and survival of colorectal cancer.","volume":"135","author":"Hossain","year":"2021","journal-title":"Comput Biol Med"},{"key":"R30-20250124","first-page":"489","article-title":"Bioinformatics-based identification of the key genes associated with prostate cancer.","volume":"27","author":"Zhao","year":"2021","journal-title":"Zhonghua Nan Ke Xue"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T23:00:19Z","timestamp":1737759619000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041357","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]}}}